Oral ciprofloxacin as prophylaxis in gastroduodenal surgery
One hundred and fifty patients undergoing gastroduodenal surgery were randomly allocated to receive intravenous (iv) cefuroxime, iv ciprofloxacin or oral ciprofloxacin as prophylaxis. There were no differences in the incidence of postoperative infection complications or duration of stay among the th...
Gespeichert in:
| Veröffentlicht in: | The Journal of hospital infection 1995-07, Vol.30 (3), p.211-216 |
|---|---|
| Hauptverfasser: | , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 216 |
|---|---|
| container_issue | 3 |
| container_start_page | 211 |
| container_title | The Journal of hospital infection |
| container_volume | 30 |
| creator | McArdle, C.S. Morran, C.G. Anderson, J.R. Pettit, L. Gemmell, C.G. Sleigh, J.D. Tillotson, G.S. |
| description | One hundred and fifty patients undergoing gastroduodenal surgery were randomly allocated to receive intravenous (iv) cefuroxime, iv ciprofloxacin or oral ciprofloxacin as prophylaxis. There were no differences in the incidence of postoperative infection complications or duration of stay among the three groups. Oral ciprofloxacin offers obvious advantages in terms of ease of administration and cost. |
| doi_str_mv | 10.1016/S0195-6701(95)90316-X |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_77805247</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S019567019590316X</els_id><sourcerecordid>77805247</sourcerecordid><originalsourceid>FETCH-LOGICAL-c389t-a0876049c49fb63a3134217227b086cda99697787510521707ab8e3ea6f8b6e93</originalsourceid><addsrcrecordid>eNqFkF9LwzAUxYMoc04_wqAPIvpQTZomafBBZPgPBntQYW8hTW9npGtn0sr27c22slefLrnnd3IPB6ExwbcEE373jolkMReYXEt2IzElPJ4foSFhNIkTSeUxGh6QU3Tm_TfGOOzZAA0yliRCiCG6nzldRcauXFNWzVobW0faR-G5-tpUem19FDYL7VvXFF1TQB1w37kFuM05Oil15eGinyP0-fz0MXmNp7OXt8njNDY0k22scSY4TqVJZZlzqimhaUJECJDjjJtCS8mlEJlgBLMgYKHzDChoXmY5B0lH6Gr_b0j104Fv1dJ6A1Wla2g6r4I3GFMRQLYHjWu8d1CqlbNL7TaKYLUtTe1KU9tGVJi70tQ8-Mb9gS5fQnFw9S0F_bLXtTe6Kp2ujfUHjPJt8DRgD3sMQhm_FpzyxkJtoLAOTKuKxv4T5A-RTofp</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>77805247</pqid></control><display><type>article</type><title>Oral ciprofloxacin as prophylaxis in gastroduodenal surgery</title><source>MEDLINE</source><source>Access via ScienceDirect (Elsevier)</source><creator>McArdle, C.S. ; Morran, C.G. ; Anderson, J.R. ; Pettit, L. ; Gemmell, C.G. ; Sleigh, J.D. ; Tillotson, G.S.</creator><creatorcontrib>McArdle, C.S. ; Morran, C.G. ; Anderson, J.R. ; Pettit, L. ; Gemmell, C.G. ; Sleigh, J.D. ; Tillotson, G.S.</creatorcontrib><description>One hundred and fifty patients undergoing gastroduodenal surgery were randomly allocated to receive intravenous (iv) cefuroxime, iv ciprofloxacin or oral ciprofloxacin as prophylaxis. There were no differences in the incidence of postoperative infection complications or duration of stay among the three groups. Oral ciprofloxacin offers obvious advantages in terms of ease of administration and cost.</description><identifier>ISSN: 0195-6701</identifier><identifier>EISSN: 1532-2939</identifier><identifier>DOI: 10.1016/S0195-6701(95)90316-X</identifier><identifier>PMID: 8522777</identifier><language>eng</language><publisher>Kent: Elsevier Ltd</publisher><subject><![CDATA[Administration, Oral ; Anti-Infective Agents - administration & dosage ; Anti-Infective Agents - therapeutic use ; Antibacterial agents ; Antibiotic Prophylaxis ; Antibiotics. Antiinfectious agents. Antiparasitic agents ; Bacterial Infections - prevention & control ; Biological and medical sciences ; Cefuroxime - administration & dosage ; Cefuroxime - therapeutic use ; Ciprofloxacin ; Ciprofloxacin - administration & dosage ; Ciprofloxacin - therapeutic use ; Duodenum - surgery ; Female ; Humans ; Injections, Intravenous ; Length of Stay - statistics & numerical data ; Male ; Medical sciences ; Middle Aged ; Pharmacology. Drug treatments ; Scotland ; Stomach - surgery ; Surgical Wound Infection - prevention & control]]></subject><ispartof>The Journal of hospital infection, 1995-07, Vol.30 (3), p.211-216</ispartof><rights>1995</rights><rights>1995 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c389t-a0876049c49fb63a3134217227b086cda99697787510521707ab8e3ea6f8b6e93</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/S0195-6701(95)90316-X$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>315,781,785,3551,27929,27930,46000</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=3610524$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/8522777$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>McArdle, C.S.</creatorcontrib><creatorcontrib>Morran, C.G.</creatorcontrib><creatorcontrib>Anderson, J.R.</creatorcontrib><creatorcontrib>Pettit, L.</creatorcontrib><creatorcontrib>Gemmell, C.G.</creatorcontrib><creatorcontrib>Sleigh, J.D.</creatorcontrib><creatorcontrib>Tillotson, G.S.</creatorcontrib><title>Oral ciprofloxacin as prophylaxis in gastroduodenal surgery</title><title>The Journal of hospital infection</title><addtitle>J Hosp Infect</addtitle><description>One hundred and fifty patients undergoing gastroduodenal surgery were randomly allocated to receive intravenous (iv) cefuroxime, iv ciprofloxacin or oral ciprofloxacin as prophylaxis. There were no differences in the incidence of postoperative infection complications or duration of stay among the three groups. Oral ciprofloxacin offers obvious advantages in terms of ease of administration and cost.</description><subject>Administration, Oral</subject><subject>Anti-Infective Agents - administration & dosage</subject><subject>Anti-Infective Agents - therapeutic use</subject><subject>Antibacterial agents</subject><subject>Antibiotic Prophylaxis</subject><subject>Antibiotics. Antiinfectious agents. Antiparasitic agents</subject><subject>Bacterial Infections - prevention & control</subject><subject>Biological and medical sciences</subject><subject>Cefuroxime - administration & dosage</subject><subject>Cefuroxime - therapeutic use</subject><subject>Ciprofloxacin</subject><subject>Ciprofloxacin - administration & dosage</subject><subject>Ciprofloxacin - therapeutic use</subject><subject>Duodenum - surgery</subject><subject>Female</subject><subject>Humans</subject><subject>Injections, Intravenous</subject><subject>Length of Stay - statistics & numerical data</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Pharmacology. Drug treatments</subject><subject>Scotland</subject><subject>Stomach - surgery</subject><subject>Surgical Wound Infection - prevention & control</subject><issn>0195-6701</issn><issn>1532-2939</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1995</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkF9LwzAUxYMoc04_wqAPIvpQTZomafBBZPgPBntQYW8hTW9npGtn0sr27c22slefLrnnd3IPB6ExwbcEE373jolkMReYXEt2IzElPJ4foSFhNIkTSeUxGh6QU3Tm_TfGOOzZAA0yliRCiCG6nzldRcauXFNWzVobW0faR-G5-tpUem19FDYL7VvXFF1TQB1w37kFuM05Oil15eGinyP0-fz0MXmNp7OXt8njNDY0k22scSY4TqVJZZlzqimhaUJECJDjjJtCS8mlEJlgBLMgYKHzDChoXmY5B0lH6Gr_b0j104Fv1dJ6A1Wla2g6r4I3GFMRQLYHjWu8d1CqlbNL7TaKYLUtTe1KU9tGVJi70tQ8-Mb9gS5fQnFw9S0F_bLXtTe6Kp2ujfUHjPJt8DRgD3sMQhm_FpzyxkJtoLAOTKuKxv4T5A-RTofp</recordid><startdate>19950701</startdate><enddate>19950701</enddate><creator>McArdle, C.S.</creator><creator>Morran, C.G.</creator><creator>Anderson, J.R.</creator><creator>Pettit, L.</creator><creator>Gemmell, C.G.</creator><creator>Sleigh, J.D.</creator><creator>Tillotson, G.S.</creator><general>Elsevier Ltd</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>19950701</creationdate><title>Oral ciprofloxacin as prophylaxis in gastroduodenal surgery</title><author>McArdle, C.S. ; Morran, C.G. ; Anderson, J.R. ; Pettit, L. ; Gemmell, C.G. ; Sleigh, J.D. ; Tillotson, G.S.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c389t-a0876049c49fb63a3134217227b086cda99697787510521707ab8e3ea6f8b6e93</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1995</creationdate><topic>Administration, Oral</topic><topic>Anti-Infective Agents - administration & dosage</topic><topic>Anti-Infective Agents - therapeutic use</topic><topic>Antibacterial agents</topic><topic>Antibiotic Prophylaxis</topic><topic>Antibiotics. Antiinfectious agents. Antiparasitic agents</topic><topic>Bacterial Infections - prevention & control</topic><topic>Biological and medical sciences</topic><topic>Cefuroxime - administration & dosage</topic><topic>Cefuroxime - therapeutic use</topic><topic>Ciprofloxacin</topic><topic>Ciprofloxacin - administration & dosage</topic><topic>Ciprofloxacin - therapeutic use</topic><topic>Duodenum - surgery</topic><topic>Female</topic><topic>Humans</topic><topic>Injections, Intravenous</topic><topic>Length of Stay - statistics & numerical data</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Pharmacology. Drug treatments</topic><topic>Scotland</topic><topic>Stomach - surgery</topic><topic>Surgical Wound Infection - prevention & control</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>McArdle, C.S.</creatorcontrib><creatorcontrib>Morran, C.G.</creatorcontrib><creatorcontrib>Anderson, J.R.</creatorcontrib><creatorcontrib>Pettit, L.</creatorcontrib><creatorcontrib>Gemmell, C.G.</creatorcontrib><creatorcontrib>Sleigh, J.D.</creatorcontrib><creatorcontrib>Tillotson, G.S.</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>The Journal of hospital infection</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>McArdle, C.S.</au><au>Morran, C.G.</au><au>Anderson, J.R.</au><au>Pettit, L.</au><au>Gemmell, C.G.</au><au>Sleigh, J.D.</au><au>Tillotson, G.S.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Oral ciprofloxacin as prophylaxis in gastroduodenal surgery</atitle><jtitle>The Journal of hospital infection</jtitle><addtitle>J Hosp Infect</addtitle><date>1995-07-01</date><risdate>1995</risdate><volume>30</volume><issue>3</issue><spage>211</spage><epage>216</epage><pages>211-216</pages><issn>0195-6701</issn><eissn>1532-2939</eissn><abstract>One hundred and fifty patients undergoing gastroduodenal surgery were randomly allocated to receive intravenous (iv) cefuroxime, iv ciprofloxacin or oral ciprofloxacin as prophylaxis. There were no differences in the incidence of postoperative infection complications or duration of stay among the three groups. Oral ciprofloxacin offers obvious advantages in terms of ease of administration and cost.</abstract><cop>Kent</cop><pub>Elsevier Ltd</pub><pmid>8522777</pmid><doi>10.1016/S0195-6701(95)90316-X</doi><tpages>6</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0195-6701 |
| ispartof | The Journal of hospital infection, 1995-07, Vol.30 (3), p.211-216 |
| issn | 0195-6701 1532-2939 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_77805247 |
| source | MEDLINE; Access via ScienceDirect (Elsevier) |
| subjects | Administration, Oral Anti-Infective Agents - administration & dosage Anti-Infective Agents - therapeutic use Antibacterial agents Antibiotic Prophylaxis Antibiotics. Antiinfectious agents. Antiparasitic agents Bacterial Infections - prevention & control Biological and medical sciences Cefuroxime - administration & dosage Cefuroxime - therapeutic use Ciprofloxacin Ciprofloxacin - administration & dosage Ciprofloxacin - therapeutic use Duodenum - surgery Female Humans Injections, Intravenous Length of Stay - statistics & numerical data Male Medical sciences Middle Aged Pharmacology. Drug treatments Scotland Stomach - surgery Surgical Wound Infection - prevention & control |
| title | Oral ciprofloxacin as prophylaxis in gastroduodenal surgery |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-11T16%3A35%3A59IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Oral%20ciprofloxacin%20as%20prophylaxis%20in%20gastroduodenal%20surgery&rft.jtitle=The%20Journal%20of%20hospital%20infection&rft.au=McArdle,%20C.S.&rft.date=1995-07-01&rft.volume=30&rft.issue=3&rft.spage=211&rft.epage=216&rft.pages=211-216&rft.issn=0195-6701&rft.eissn=1532-2939&rft_id=info:doi/10.1016/S0195-6701(95)90316-X&rft_dat=%3Cproquest_cross%3E77805247%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=77805247&rft_id=info:pmid/8522777&rft_els_id=S019567019590316X&rfr_iscdi=true |